Glucagon-like peptide-1 receptor agonists to treat chronic kidney disease associated with type 2 diabetes

被引：0
作者：
Khan, Irfan [1 ]
Lanktree, Matthew B. [2 ]
机构：
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] McMaster Univ, Dept Med Ainsi Que Methodes Donnees & Incidences R, Hamilton, ON, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2025年 / 197卷 / 06期
关键词：
D O I：
10.1503/cmaj.240469-f
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E165 / E166
页数：2
相关论文
共 50 条
[21]   Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes [J].
Lovshin, Julie A. .
CANADIAN JOURNAL OF DIABETES, 2017, 41 (05) :524-535
[22]   The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes [J].
Yin, Win L. ;
Bain, Steve C. ;
Min, Thinzar .
DIABETES THERAPY, 2020, 11 (04) :835-844
[23]   Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes [J].
Tran, Kelvin Lingjet ;
Park, Young In ;
Pandya, Shalin ;
Muliyil, Navin John ;
Jensen, Brandon David ;
Huynh, Kovin ;
Nguyen, Quang T. .
AMERICAN HEALTH AND DRUG BENEFITS, 2017, 10 (04) :178-187
[24]   Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease A Review [J].
Honigberg, Michael C. ;
Chang, Lee-Shing ;
McGuire, Darren K. ;
Plutzky, Jorge ;
Aroda, Vanita R. ;
Vaduganathan, Muthiah .
JAMA CARDIOLOGY, 2020, 5 (10) :1182-1190
[25]   Glucagon-like peptide receptor-1 receptor agonists: The emerging fourth pillar in type 2 diabetes and chronic kidney disease? [J].
Ling, James ;
Chow, Elaine .
MED, 2024, 5 (08) :845-847
[26]   Relationship between Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Disease in Chronic Respiratory Disease and Diabetes [J].
Yeh, Jun-Jun ;
Li, Chih-Chien ;
Tan, Chang-Wen ;
Li, Chia-Hsun ;
Tsai, Tung-Han ;
Kao, Chia-Hung .
BIOMEDICINES, 2024, 12 (03)
[27]   Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus A Role in Cardiovascular Disease [J].
Smilowitz, Nathaniel R. ;
Donnino, Robert ;
Schwartzbard, Arthur .
CIRCULATION, 2014, 129 (22) :2305-2312
[28]   The Role of Glucagon-Like Peptide-1 Receptor Agonists in Chronic Obstructive Pulmonary Disease [J].
Wang, Wenwen ;
Mei, Aihua ;
Qian, Hang ;
Li, Dongfeng ;
Xu, Hao ;
Chen, Jishun ;
Yang, Handong ;
Min, Xinwen ;
Li, Chunlei ;
Cheng, Li ;
Chen, Jun .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 :129-137
[29]   Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer? [J].
Resnick, Ortal ;
Bril, Fernando ;
Beauchamp, Giovanna .
FRONTIERS IN ENDOCRINOLOGY, 2025, 15
[30]   Glucagon-like peptide-1 receptor agonists decreases albuminuria in overweight patients with type 2 diabetes [J].
Bulum, T. ;
Blaslov, K. ;
Tomic, M. ;
Duvnjak, L. .
DIABETOLOGIA, 2015, 58 :S532-S533
12345